| Recruiting | PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients Cancer-related Fatigue | Phase 2 | 2023-05-17 |
| Completed | PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer Cancer-related Fatigue, Survival, Tumor, Esophageal | Phase 2 | 2019-02-19 |
| Completed | PG2 Treatment Among Stage II/III Breast Cancer Patients Receiving Adjuvant Chemotherapy Cancer-related Fatigue, Neutropenia, Malignant | Phase 2 | 2018-03-01 |
| Withdrawn | Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer Cancer, Surgery, Fatigue | Phase 2 | 2014-02-01 |
| Completed | Study of PHN131 in Patients After Surgery Analgesia Disorder | Phase 2 / Phase 3 | 2013-04-30 |
| Terminated | A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concur Cancer-related Fatigue | Phase 2 | 2012-12-01 |
| Completed | PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care Cancer-related Fatigue | Phase 4 | 2012-11-01 |
| Terminated | Study of PHN131 in Healthy Volunteers Analgesia Disorder | — | 2011-10-01 |
| Completed | The Pilot Clinical Study of PG2 Injection on Hemorrhagic Stroke Hemorrhagic Stroke | EARLY_Phase 1 | 2011-03-01 |
| Completed | Effects of PH3 in Diabetic Nephropathy Diabetic Nephropathy | Phase 2 | 2010-08-01 |
| Terminated | Safety and Efficacy Study in Hepatitis C Patients With PHN121 Hepatitis C Virus Infection | Phase 1 / Phase 2 | 2009-09-01 |
| Completed | Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients Idiopathic Thrombocytopenic Purpura (ITP) | Phase 2 | 2008-09-01 |
| Completed | Bioavailability, Pharmacokinetics and Safety Evaluation of Phencynonate Hydrochloride in Healthy Volunteers Healthy | Phase 1 | 2008-08-01 |
| Completed | Study of PH3 for the Prevention of Osteoporosis in Postmenopausal Women Osteoporosis | Phase 2 | 2008-02-01 |
| Completed | A Phase II Clinical Study of PDC-748 in Patients With Acute Cough Acute Cough | Phase 2 | 2007-10-01 |
| Terminated | Complementary Treatment of PG2 to Improve Clinical Benefit Response and Quality of Life in Fatigue Quality of Life, Fatigue, Complementary | Phase 2 / Phase 3 | 2007-09-01 |
| Completed | PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care Fatigue | Phase 2 / Phase 3 | 2007-08-01 |
| Completed | PG2 Phase I/II Clinical Study Intravenously Administered in Patients With Advanced Malignancy Neoplasm Metastasis, Neoplasm Recurrence | Phase 1 / Phase 2 | 2001-12-01 |